Lite Strategy, Inc. — Director's Dealing 2021

May 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2021-05-25

Reporting Person: GOLD DANIEL P PHD (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-25	Common Stock	M	5000	$2.52	Acquired	458632	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-25	Stock Option (Right to Buy)	$2.52	M	5000	Disposed	2029-07-01	Common Stock (5000)	Direct

Footnotes

F1: 80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.

F2: 306,667 of the options are fully vested and currently exercisable. The remaining 368,333 options will vest in equal monthly installments through July 1, 2023.